[
  {
    "ts": null,
    "headline": "DexCom Inc. stock outperforms competitors on strong trading day",
    "summary": "DexCom Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=d1e6f094bdf315732919a71c53c517c23f2d746cb4a557da8cf28824c9b85a3b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733850120,
      "headline": "DexCom Inc. stock outperforms competitors on strong trading day",
      "id": 131946420,
      "image": "",
      "related": "DXCM",
      "source": "MarketWatch",
      "summary": "DexCom Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=d1e6f094bdf315732919a71c53c517c23f2d746cb4a557da8cf28824c9b85a3b"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom shares up as Diabetes Association updates guidelines",
    "summary": "Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults with type 2 diabetes who are not on insulin.",
    "url": "https://finnhub.io/api/news?id=9de4753cc237ffc11382e9804fa533d09cec37f07d98a4310db4c06769cb6080",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733847707,
      "headline": "Dexcom shares up as Diabetes Association updates guidelines",
      "id": 131915818,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Investing.com -- DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults with type 2 diabetes who are not on insulin.",
      "url": "https://finnhub.io/api/news?id=9de4753cc237ffc11382e9804fa533d09cec37f07d98a4310db4c06769cb6080"
    }
  },
  {
    "ts": null,
    "headline": "DexCom: Brighter 2025 From Stelo Ramp",
    "summary": "DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors remains strong. Click here to read.",
    "url": "https://finnhub.io/api/news?id=24e606957898d6705dd0ad9e6eb0a3685d8395d6710553a478f3365c00125b44",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733843934,
      "headline": "DexCom: Brighter 2025 From Stelo Ramp",
      "id": 131906899,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1595115113/image_1595115113.jpg?io=getty-c-w1536",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors remains strong. Click here to read.",
      "url": "https://finnhub.io/api/news?id=24e606957898d6705dd0ad9e6eb0a3685d8395d6710553a478f3365c00125b44"
    }
  },
  {
    "ts": null,
    "headline": "BNY Mellon Small/Mid Cap Growth Fund Q3 2024 Commentary",
    "summary": "The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.",
    "url": "https://finnhub.io/api/news?id=15b8b386ed3039426c4013a4ab236acfbfa303572c285c0bbd74c2bb86b194e9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733806980,
      "headline": "BNY Mellon Small/Mid Cap Growth Fund Q3 2024 Commentary",
      "id": 131899256,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1158571591/image_1158571591.jpg?io=getty-c-w1536",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.",
      "url": "https://finnhub.io/api/news?id=15b8b386ed3039426c4013a4ab236acfbfa303572c285c0bbd74c2bb86b194e9"
    }
  }
]